» Articles » PMID: 38716087

Impact of Dyslipidemia on Tear Film and Meibomian Gland Dysfunction: A Cross-Sectional Study of the Interplay Between Serum Lipid Profile and Ocular Surface Health

Overview
Journal J Ophthalmol
Publisher Wiley
Specialty Ophthalmology
Date 2024 May 8
PMID 38716087
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the relationship between dyslipidemia and dry eye disease (DED), as well as its influence on tear film and meibomian glands.

Methods: This cross-sectional study included 40 patients with a mean age of 35.2 ± 13.9 years without any history of dyslipidemia. DED and serum lipid profile were evaluated after 8 hours of fasting. Patients were classified according to serum lipid levels with the following cut-off values: total cholesterol (TC) (200 mg/dl), high-density lipoprotein (HDL) (40 mg/dl), low-density lipoprotein (LDL) (130 mg/dl), and triglycerides (TG) (150 mg/dl). The relationship between serum lipid levels and DED was analyzed with the following variables: dry eye questionnaire-5 (DEQ-5), first (F-NIBUT) and average (A-NIBUT) noninvasive breakup time, tear meniscus height (TMH), lipid layer grade (LLG), conjunctival bulbar redness (CBR), and upper (U-LAMG) and lower (L-LAMG) loss area of meibomian glands.

Results: Regarding tear film, patients with elevated TC and LDL levels reported significantly higher DEQ-5 scores and TMH ( < 0.05), while those with lower HDL levels showed significantly higher LLG ( < 0.05). Regarding MGD, patients with elevated TC, LDL, and TG, as well as lower HDL levels showed significantly higher L-LAMG ( < 0.05). HDL was correlated with LLG ( < 0.05), while TC was correlated with TMH ( < 0.05) and L-LAMG ( < 0.05), respectively.

Conclusions: Disorders in TC, HDL, LDL, and TG levels were associated with DED, having an impact on the tear film and meibomian glands, specifically in DEQ-5 scores, LLG, and L-LAMG.

Citing Articles

Diurnal rhythm-modulated transcriptome analysis of meibomian gland in hyperlipidemic mice using RNA sequencing.

Zhang Q, Su J, Chen J, Wu S, Qi X, Chu M Int Ophthalmol. 2025; 45(1):57.

PMID: 39890715 DOI: 10.1007/s10792-025-03431-7.

References
1.
Ha M, Song J, Park S, Han K, Hwang H, Kim H . Relationship between serum lipid level and meibomian gland dysfunction subtype in Korea using propensity score matching. Sci Rep. 2021; 11(1):16102. PMC: 8352992. DOI: 10.1038/s41598-021-95599-y. View

2.
Setu M, Horstmann J, Schmidt S, Stern M, Steven P . Deep learning-based automatic meibomian gland segmentation and morphology assessment in infrared meibography. Sci Rep. 2021; 11(1):7649. PMC: 8027879. DOI: 10.1038/s41598-021-87314-8. View

3.
Fukuyama N, Homma K, Wakana N, Kudo K, Suyama A, Ohazama H . Validation of the Friedewald Equation for Evaluation of Plasma LDL-Cholesterol. J Clin Biochem Nutr. 2008; 43(1):1-5. PMC: 2459246. DOI: 10.3164/jcbn.2008036. View

4.
Guliani B, Bhalla A, Naik M . Association of the severity of meibomian gland dysfunction with dyslipidemia in Indian population. Indian J Ophthalmol. 2018; 66(10):1411-1416. PMC: 6173020. DOI: 10.4103/ijo.IJO_1256_17. View

5.
Dao A, Spindle J, Harp B, Jacob A, Chuang A, Yee R . Association of dyslipidemia in moderate to severe meibomian gland dysfunction. Am J Ophthalmol. 2010; 150(3):371-375.e1. DOI: 10.1016/j.ajo.2010.04.016. View